Maitri Enterprises Ltd
Incorporated in 1991, Maitri Enterprises Ltd is engaged in the business of Pharmaceutical products
- Market Cap ₹ 15.4 Cr.
- Current Price ₹ 35.1
- High / Low ₹ 51.3 / 18.7
- Stock P/E 14.2
- Book Value ₹ 12.9
- Dividend Yield 0.00 %
- ROCE 16.3 %
- ROE 19.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
- Debtor days have improved from 67.7 to 29.3 days.
- Company's working capital requirements have reduced from 77.7 days to 40.0 days
Cons
- Stock is trading at 2.71 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.43% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.03 | 0.55 | 0.32 | 0.64 | 0.69 | 6.16 | 6.66 | 4.54 | 12.58 | 9.87 | 18.28 | 28.62 | |
0.20 | 0.63 | 0.41 | 0.71 | 0.73 | 6.17 | 6.67 | 4.45 | 12.17 | 9.28 | 17.82 | 26.36 | |
Operating Profit | -0.17 | -0.08 | -0.09 | -0.07 | -0.04 | -0.01 | -0.01 | 0.09 | 0.41 | 0.59 | 0.46 | 2.26 |
OPM % | -566.67% | -14.55% | -28.12% | -10.94% | -5.80% | -0.16% | -0.15% | 1.98% | 3.26% | 5.98% | 2.52% | 7.90% |
0.06 | 0.11 | 0.11 | 0.10 | 0.10 | 0.08 | 0.27 | 0.08 | 0.03 | 0.03 | 0.26 | -1.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 | 0.07 | 0.09 | 0.55 | 0.73 |
Depreciation | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.03 | 0.04 | 0.05 | 0.07 | 0.06 | 0.05 | 0.07 |
Profit before tax | -0.13 | 0.01 | 0.00 | 0.02 | 0.04 | 0.02 | 0.21 | 0.10 | 0.30 | 0.47 | 0.12 | 0.46 |
Tax % | 0.00% | 0.00% | 0.00% | 25.00% | 50.00% | 23.81% | 40.00% | 26.67% | 29.79% | 33.33% | 34.78% | |
-0.13 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.16 | 0.07 | 0.22 | 0.34 | 0.08 | 0.30 | |
EPS in Rs | -0.27 | 0.02 | 0.00 | 0.11 | 0.11 | 0.05 | 0.84 | 0.37 | 0.50 | 0.77 | 0.18 | 0.68 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 48% |
5 Years: | 34% |
3 Years: | 32% |
TTM: | 57% |
Compounded Profit Growth | |
---|---|
10 Years: | 60% |
5 Years: | 47% |
3 Years: | 70% |
TTM: | 1263% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 36% |
3 Years: | -3% |
1 Year: | 13% |
Return on Equity | |
---|---|
10 Years: | 7% |
5 Years: | 8% |
3 Years: | 9% |
Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.75 | 4.75 | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 | 4.40 | 4.40 | 4.40 | 4.40 |
Reserves | -2.81 | -2.80 | -0.14 | -0.13 | -0.10 | -0.09 | 0.07 | 0.14 | 0.56 | 0.90 | 0.98 | 1.29 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.40 | 1.77 | 2.41 | 9.99 | 6.30 | |
0.09 | 0.18 | 0.11 | 0.40 | 0.26 | 3.28 | 2.59 | 3.96 | 4.91 | 5.76 | 6.29 | 4.46 | |
Total Liabilities | 2.03 | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 6.40 | 11.64 | 13.47 | 21.66 | 16.45 |
0.11 | 0.09 | 0.08 | 0.06 | 0.06 | 0.13 | 0.10 | 0.22 | 0.18 | 0.15 | 0.16 | 0.18 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.37 | 3.37 | 7.02 | 6.83 |
1.92 | 2.04 | 1.79 | 2.11 | 2.00 | 4.96 | 4.57 | 6.18 | 8.09 | 9.95 | 14.48 | 9.44 | |
Total Assets | 2.03 | 2.13 | 1.87 | 2.17 | 2.06 | 5.09 | 4.67 | 6.40 | 11.64 | 13.47 | 21.66 | 16.45 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.11 | 0.00 | 0.02 | -0.22 | 0.00 | 0.17 | 0.64 | -0.17 | -0.62 | -0.20 | -1.70 | 2.60 | |
-0.01 | 0.00 | 0.00 | 0.00 | -0.01 | -0.08 | -0.62 | -0.06 | -3.39 | -0.26 | -5.24 | 1.78 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.27 | 3.99 | 0.55 | 7.03 | -4.39 | |
Net Cash Flow | -0.12 | 0.00 | 0.02 | -0.22 | -0.02 | 0.10 | 0.01 | 0.04 | -0.01 | 0.09 | 0.09 | -0.02 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 3,163.33 | 106.18 | 433.44 | 250.94 | 333.26 | 81.77 | 60.29 | 126.22 | 67.60 | 68.78 | 105.03 | 29.33 |
Inventory Days | 7,178.33 | 419.75 | 580.68 | 423.07 | 304.17 | 123.56 | 132.35 | 318.36 | 140.85 | 273.63 | 129.56 | 83.97 |
Days Payable | 851.67 | 155.12 | 182.50 | 331.82 | 174.90 | 203.62 | 155.50 | 397.44 | 145.93 | 242.72 | 124.49 | 74.98 |
Cash Conversion Cycle | 9,490.00 | 370.81 | 831.62 | 342.19 | 462.53 | 1.71 | 37.14 | 47.14 | 62.52 | 99.70 | 110.10 | 38.32 |
Working Capital Days | 19,831.67 | 1,101.64 | 1,882.03 | 941.02 | 893.99 | 67.55 | 44.39 | 79.59 | 56.58 | 96.89 | 96.04 | 40.05 |
ROCE % | -6.48% | 0.51% | 0.00% | 1.13% | 2.80% | 2.22% | 11.31% | 5.31% | 8.07% | 7.76% | 5.81% | 16.30% |
Documents
Announcements
- Closure of Trading Window 28 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Audited Financial Results are published in two newspaper namely; 1. Free Press in English Edition 2. Lokmitra in Gujarati Language.
- Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended On March 31, 2025 30 May
- Audited (Standalone And Consolidated) Financial Results For The Quarter And Year Ended On March 31, 2025 30 May
-
Board Meeting Outcome for Outcome Of 2Nd (02/2025-26) Board Meeting Of The Board
30 May - Approved audited standalone and consolidated financial results for FY ended March 31, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
a) Trading of Pharmaceutical & Medical Goods
b) Manufacturing of metal furniture
c) Trading of building materials